Skip to main content

Animations

MJFF Publications

4601 - 4610 of 9036 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2020
  • 2023
  • 2021
  • 2013
  • 2022
  • 2014
  • 2018
  • 2019
  • Summary Details
    OPEN
    Title: Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0189161
    Citation Count: 179
  • Summary Details
    OPEN
    Title: Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0186508
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Identifying and predicting Parkinson’s disease subtypes through trajectory clustering via bipartite networks
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0233296
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 at a glance
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/jcs.259724
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868
    Citation Count: 185
  • Summary Details
    OPEN
    Title: Screening for impulse control symptoms in patients with de novo Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e31827b915c
    Citation Count: 189
  • Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)
    2022
    Summary Details
    RESTRICTED
    Title: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Course of psychiatric symptoms and global cognition in early Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000801
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Longitudinal analysis of impulse control disorders in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000005816
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Unique white matter structural connectivity in early-stage drug-naive Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000008867
    Citation Count: 49
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.